NATLEAN
Metabolite-based support for appetite and weight after GLP-1 therapy
metabolize.life/products/natlean
Community-submitted · content unverified. This organization has not verified ownership or the information in this profile.
About
NATLEAN is Metabolize's first Precision Metabolite consumer product, developed from licensed Stanford Medicine research and planned for a January 2027 launch. It is positioned for people coming off GLP-1 drugs who want biology-backed support for appetite and weight management; the product page is currently on waitlist.
- Added via
- web
- Ownership
- unclaimed
Where to go
For people
- Homepagemetabolize.life/products/natlean
For agents
Nothing listed yet.
Product details
- Product kind
- Other